First Time Loading...

BioNTech SE
NASDAQ:BNTX

Watchlist Manager
BioNTech SE Logo
BioNTech SE
NASDAQ:BNTX
Watchlist
Price: 92.44 USD 0.17%
Updated: May 15, 2024

BioNTech SE
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNTech SE
Net Income (Common) Peer Comparison

Comparables:
MOR
CVAC
IMTX
BIO
FYB

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
BioNTech SE
NASDAQ:BNTX
Net Income (Common)
€930.3m
CAGR 3-Years
296%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Net Income (Common)
-€460.3m
CAGR 3-Years
-38%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Net Income (Common)
-€260.2m
CAGR 3-Years
-26%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Net Income (Common)
-€97m
CAGR 3-Years
23%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Net Income (Common)
€127m
CAGR 3-Years
N/A
CAGR 5-Years
-7%
CAGR 10-Years
15%
Formycon AG
XETRA:FYB
Net Income (Common)
€75.8m
CAGR 3-Years
N/A
CAGR 5-Years
61%
CAGR 10-Years
N/A

See Also

What is BioNTech SE's Net Income (Common)?
Net Income (Common)
930.3m EUR

Based on the financial report for Dec 31, 2023, BioNTech SE's Net Income (Common) amounts to 930.3m EUR.

What is BioNTech SE's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
296%

Over the last year, the Net Income (Common) growth was -90%. The average annual Net Income (Common) growth rates for BioNTech SE have been 296% over the past three years .